Loading company…
Shenzhen Tyercan Biopharm researches and develops targeted anticancer and immunosuppressive drugs.
Established in 2017 and based in Shenzhen, China, Shenzhen Tyercan Biopharm is a pharmaceutical company focused on targeted drug research and development. It develops peptide-targeted anticancer drugs and targeted immunosuppressive drugs for tumors, organ transplantation, and autoimmune diseases. The company plans to advance preclinical studies, regulatory applications, and clinical trials.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in